Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker

A multi-parameter response prediction model for rituximab in rheumatoid arthritis

(2018) Tamarah D. de Jong et al.   JOINT BONE SPINE

Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine

(2015) Javier Rodríguez-Carrio et al.   CLINICAL SCIENCE

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab

(2015) Tamarah D de Jong et al.   ARTHRITIS RESEARCH & THERAPY

An essential role for IFN-β in the induction of IFN-stimulated gene expression by LPS in macrophages

(2014) Faruk Sheikh et al.   JOURNAL OF LEUKOCYTE BIOLOGY

IFNα Serum Levels Are Associated with Endothelial Progenitor Cells Imbalance and Disease Features in Rheumatoid Arthritis Patients

(2014) Javier Rodríguez-Carrio et al.   PLoS One

Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis

(2014) T. Cantaert et al.   RHEUMATOLOGY

The type I IFN signature as a biomarker of preclinical rheumatoid arthritis

(2013) Joyce Lübbers et al.   ANNALS OF THE RHEUMATIC DISEASES

The interferon signature andSTAT1expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment

(2012) Rachael A. Gordon et al.   ARTHRITIS AND RHEUMATISM

The interferon signature in autoimmune diseases

(2012) Lars Rönnblom et al.   CURRENT OPINION IN RHEUMATOLOGY

Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients

(2012) Emily C. Somers et al.   PLoS One

Overview of the biology of type I interferons

(2012) George D Kalliolias et al.   ARTHRITIS RESEARCH & THERAPY

Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis

(2011) S. Vosslamber et al.   ANNALS OF THE RHEUMATIC DISEASES

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

(2011) B. W. Higgs et al.   ANNALS OF THE RHEUMATIC DISEASES

Importance of Correlation between Gene Expression Levels: Application to the Type I Interferon Signature in Rheumatoid Arthritis

(2011) Frédéric Reynier et al.   PLoS One

The type I interferon system in the development of lupus

(2011) Lars Rönnblom et al.   SEMINARS IN IMMUNOLOGY

Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-β/α ratios in rheumatoid arthritis patients: A post hoc analysis of a predominantly Hispanic cohort

(2010) Clio P. Mavragani et al.   ARTHRITIS AND RHEUMATISM

Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis

(2010) Lisa G. M. van Baarsen et al.   ARTHRITIS AND RHEUMATISM

Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritis

(2010) L G M van Baarsen et al.   GENES AND IMMUNITY

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

(2010) Lisa GM van Baarsen et al.   ARTHRITIS RESEARCH & THERAPY

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

(2008) Qiong Fu et al.   ARTHRITIS RESEARCH & THERAPY